Skip to main content

Advertisement

SpringerLink
Log in

The metabolic effects of growth hormone in adipose tissue

  • Review
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

There is a general consensus that a reduction in growth hormone (GH) secretion results in obesity. However, the pathophysiologic role of GH in the metabolism of lipids is yet to be fully understood. The major somatic targets of GH are bones and muscles, but GH stimulates lipolysis and seems to regulate lipid deposition in adipose tissue. Patients with isolated GH deficiency (GHD) have enlarged fat depots due to higher fat cell volume, but their fat cell numbers are lower than those of matched controls. The treatment of patients with GH results in a relative loss of body fat and shifts both fat cell number and fat cell volume toward normal, indicating an adipogenic effect of GH. Adults with GHD are characterized by perturbations in body composition, lipid metabolism, cardiovascular risk profile, and bone mineral density. It is well established that GHD is usually accompanied by an increase in fat accumulation; GH replacement in GHD results in the reduction of fat mass, particularly abdominal fat mass. In addition, abdominal obesity results in a secondary reduction in GH secretion that is reversible with weight loss. However, whereas GH replacement in patients with GHD leads to specific depletion of intra-abdominal fat, administering GH to obese individuals does not seem to result in a consistent reduction or redistribution of body fat. Although administering GH to obese non-GHD subjects has only led to equivocal results, more recent studies indicate that GH still remains a plausible metabolic candidate.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. R.G. Rosenfeld, Growth hormone deficiency in children, in Endocrinology, ed. by L.J. Degroot, J.L. Jameson (W.B. Saunders, Philadelphia, 2001), pp. 503–519

    Google Scholar 

  2. J.O.L. Jorgensen, L. Moller, M. Krag, N. Billestrup, J.S. Christiansen, Effects of growth hormone on glucose and fat metabolism in human subjects. Endocrinol. Metab. Clin. N. Am. 36, 75–87 (2007)

    Google Scholar 

  3. N. Moller, K.C. Copeland, K.S. Nair, Growth hormone effects on protein metabolism. Endocrinol. Metab. Clin. N. Am. 36, 89–100 (2007)

    Google Scholar 

  4. N. Moller, J.O.L. Jorgensen, Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr. Rev. 30, 152–177 (2009)

    PubMed  Google Scholar 

  5. Y. Wang, S.K. Fried, R.N. Petersen, P.A. Schoknecht, Somatotropin regulates adipose tissue metabolism in neonatal swine. J. Nutr. 129, 139–145 (1999)

    PubMed  CAS  Google Scholar 

  6. D.M. Harris, F.R. Dunshea, D.E. Bauman, R.D. Boyd, S.Y. Wang, P.A. Johnson, S.D. Clarke, Effect of in vivo somatotropin treatment of growing pigs on adipose tissue lipogenesis. J. Anim. Sci. 71, 3293–3300 (1993)

    PubMed  CAS  Google Scholar 

  7. M. Wabitsch, E. Heinze, Body fat in GH-deficient children and the effect of treatment. Horm. Res. 40, 5–9 (1993)

    PubMed  CAS  Google Scholar 

  8. J.D. Veldhuis, A. Iranmanesh, K.K. Ho, M.J. Waters, M.L. Johnson, G. Lizarralde, Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J. Clin. Endocrinol. Metab. 72, 51–59 (1991)

    PubMed  CAS  Google Scholar 

  9. S.A. Beshyah, A. Henderson, R. Niththyanathan, P. Sharp, W. Richmond, D.G. Johnston, Metabolic abnormalities in growth hormone-deficient adults. II: Carbohydrate tolerance and lipid metabolism. Endocrinol. Metab. 1, 173–180 (1994)

    Google Scholar 

  10. M.L. Vance, N. Mauras, Growth hormone therapy in adults and children. N. Eng. J. Med. 341, 1206–1214 (1999)

    CAS  Google Scholar 

  11. A.L. Utz, A. Yamamoto, L. Hemphill, K.K. Miller, Growth hormone deficiency by growth hormone releasing hormone-arginine testing criteria predicts increased cardiovascular risk markers in normal young overweight and obese women. J. Clin. Endocrinol. Metab. 93, 2507–2514 (2008)

    PubMed  CAS  Google Scholar 

  12. M. Gola, S. Bonadonna, M. Doga, A. Giustina, Clinical review: Growth hormone and cardiovascular risk factors. J. Clin. Endocrinol. Metab. 90, 1864–1870 (2005)

    PubMed  CAS  Google Scholar 

  13. M. Gola, S. Bonadonna, M. Doga, G. Mazziotti, A. Giustina, Cardiovascular risk in aging and obesity: is there a role for GH. J. Endocrinol. Invest. 28, 759–767 (2005)

    PubMed  CAS  Google Scholar 

  14. L. Li, W. Ren, J. Li, J. Liu, L. Wang, X. Zheng, D. Liu, S. Li, R. Souvenir, J. Tang, Increase in serum pregnancy-associated plasma protein-A is correlated with increase in cardiovascular risk factors in adult patients with growth hormone deficiency. Endocrine 42, 375–381 (2012)

    PubMed  CAS  Google Scholar 

  15. M. Doga, S. Bonadonna, M. Gola, S.B. Solerte, G. Amato, C. Carella, A. Giustina, Current guidelines for adult GH replacement. Rev. Endocr. Metab. Disord. 6, 63–70 (2005)

    PubMed  Google Scholar 

  16. M. Gola, A. Giustina, Growth hormone deficiency and cardiovascular risk: do we need additional markers? Endocrine 42, 240–242 (2012)

    PubMed  CAS  Google Scholar 

  17. M.H. Rasmussen, Obesity, growth hormone and weight loss. Mol. Cell. Endocrinol. 316, 147–153 (2010)

    PubMed  CAS  Google Scholar 

  18. A. Iranmanesh, G. Lizarralde, J.D. Veldhuis, Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J. Clin. Endocrinol. Metab. 73, 1081–1088 (1991)

    PubMed  CAS  Google Scholar 

  19. E. Kamycheva, V. Berg, R. Jorde, Insulin-like growth factor I, growth hormone, and insulin sensitivity: the effects of a one-year cholecalciferol supplementation in middle-aged overweight and obese subjects. Endocrine. (2012) [Epub ahead of print]

  20. M.E. Molitch, D.R. Clemmons, S. Malozowski, G.R. Merriam, M.L. Vance, Evaluation and treatment of adult growth hormone deficiency: An endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 96, 1587–1609 (2011)

    PubMed  CAS  Google Scholar 

  21. U.J. Lewis, R.N. Singh, G.H. Tutwiler, M.B. Sigel, E.F. VanderLaan, W.P. VanderLaan, Human growth hormone: a complex of proteins. Recent Prog. Horm. Res. 36, 477–508 (1980)

    PubMed  CAS  Google Scholar 

  22. S.S. Abdel-Meguid, H.S. Shieh, W.W. Smith, H.E. Dayringer, B.N. Violand, L.A. Bentle, Three-dimensional structure of a genetically engineered variant of porcine growth hormone. Proc. Natl. Acad. Sci. U.S.A. 84, 6434–6437 (1987)

    PubMed  CAS  Google Scholar 

  23. A.C. Gore, J.L. Roberts, Neuroendocrine systems, in Fundamental Neuroscience, ed. by L.R. Squire, F.E. Bloom, S.K. McConnell (Elsevier Science, San Diego, 2003), pp. 1031–1065

    Google Scholar 

  24. M. Barinaga, G. Yamonoto, C. Rivier, W. Vale, R. Evans, M.G. Rosenfeld, Transcriptional regulation of growth hormone gene expression by growth hormone-releasing factor. Nature 306, 84–85 (1983)

    PubMed  CAS  Google Scholar 

  25. R.W. Holl, M.O. Thorner, D.A. Leong, Intracellular calcium concentration and growth hormone secretion in individual somatotropes: effects of growth hormone-releasing factor and somatostatin. Endocrinology 122, 2927–2932 (1988)

    PubMed  CAS  Google Scholar 

  26. A. Giustina, J.D. Velhuis, Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr. Rev. 19, 717–797 (1998)

    PubMed  CAS  Google Scholar 

  27. E.O. Reiter, R.G. Rosenfeld, Normal and aberrant growth, in Williams Textbook of Endocrinology, ed. by P.R. Larsen, H.M. Kronenberg, S. Melmed, K.S. Polonski (Elsevier Science, San Diego, 2003), pp. 1009–1014

    Google Scholar 

  28. P. Barnett, Somatostatin and somatostatin receptor physiology. Endocrine 20, 255–264 (2003)

    PubMed  CAS  Google Scholar 

  29. M.L. Hartman, A.C.S. Faria, M.L. Vance, M.T. Johnson, M.O. Thorner, J.D. Veldhuis, Temporal structure of in vivo growth hormone secretory events in humans. Am. J. Physiol. 260, E101–E110 (1991)

    PubMed  CAS  Google Scholar 

  30. N. Goldenberg, A. Barkan, Factors regulating growth hormone secretion in humans. Endocrinol. Metab. Clin. North Am. 36, 37–55 (2007)

    PubMed  CAS  Google Scholar 

  31. M. Berelowitz, M. Szabo, L.A. Frohman, L.A. Frohman, S. Firestone, L. Chu, R.L. Hintz, Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and pituitary. Science 212, 1279–1281 (1981)

    PubMed  CAS  Google Scholar 

  32. C.Y. Bowers, F. Momany, G.A. Reynolds, A. Hong, On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 114, 1537–1545 (1984)

    PubMed  CAS  Google Scholar 

  33. S. Yamashita, S. Melmed, Insulin-like growth factor I action on rat anterior pituitary cells: suppression of growth hormone secretion and messenger ribonucleic acid levels. Endocrinology 118, 176–182 (1986)

    PubMed  CAS  Google Scholar 

  34. R.G. Rosenfeld, G. Ceda, C.W. Cutler, L.A. Dollar, A.R. Hoffman, Insulin and insulin-like growth factor (somatomedin) receptors on cloned rat pituitary tumor cells. Endocrinology 117, 2008–2016 (1985)

    PubMed  CAS  Google Scholar 

  35. G.P. Ceda, R.G. Davis, R.G. Rosenfeld, A.R. Hoffman, The growth hormone (GH) releasing hormone (GHRH)/GH/somatomedin axis: evidence for rapid inhibition of GHRH-elicited GH release by insulin-like growth factors I and II. Endocrinology 120, 1658–1662 (1987)

    PubMed  CAS  Google Scholar 

  36. M.A. Vaccarello, F.B. Diamond Jr, J. Guevara-Aguirre, A.L. Rosenbloom, P.J. Fielder, S. Gargosky, P. Cohen, K. Wilson, R.G. Rosenfeld, Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor I in growth hormone receptor deficiency (GHRD)/Laron syndrome. J. Clin. Endocrinol. Metab. 77, 273–280 (1993)

    PubMed  CAS  Google Scholar 

  37. J. Bellone, G. Aimaretti, E. Bartolotta, L. Benso, B.P. Imbimbo, V. Lenhaerts, R. Deghenghi, F. Camanni, E. Ghigo, Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, before and during puberty. Clin. Endocrinol. Metab. 80, 1090–1094 (1995)

    CAS  Google Scholar 

  38. M. Korbonits, A.B. Grossman, Growth hormone-releasing peptide and its analogues. Trends Endocrinol. Metab. 6, 43–49 (1995)

    PubMed  CAS  Google Scholar 

  39. R. Birnbacher, S. Riedl, H. Frisch, Long-term treatment in children with hypopituitarism: Pubertal development and final height. Horm. Res. 49, 80–85 (1998)

    PubMed  CAS  Google Scholar 

  40. K. Takaya, H. Ariyasu, N. Kanamoto, H. Iwakura, A. Yoshimoto, M. Harada, K. Mori, Y. Komatsu, T. Usui, A. Shimatsu, Y. Ogawa, K. Hosoda, T. Akamizu, M. Kojima, K. Kangawa, K. Nakao, Ghrelin strongly stimulates growth hormone (GH) release in humans. J. Clin. Endocrinol. Metab. 85, 4908–4911 (2000)

    PubMed  CAS  Google Scholar 

  41. A.M.J. Lengyel, From growth hormone-releasing peptides to ghrelin: discovery of new modulators of GH secretion. Arq. Bras. Endocrinol. Metab. 50, 17–24 (2006)

    Google Scholar 

  42. D.G. Gardner, R.A. Nissenson, Mechanisms of hormone action, in Greenspan’s Basic & Clinical Endocrinology, ed. by D.G. Gardner, D. Shoback (McGraw-Hill Medical, New York, 2007), pp. 36–57

    Google Scholar 

  43. R.J. Brown, J.J. Adams, R.A. Pelekanos, Y. Wan, W.J. McKinstry, K. Palethorpe, R.M. Seeber, T.A. Monks, K.A. Eidne, M.W. Parker, M.J. Waters, Model for growth hormone receptor activation based on subunit rotation within a receptor dimer. Nat. Struct. Mol. Biol. 12, 814–821 (2005)

    PubMed  CAS  Google Scholar 

  44. N.J. Lanning, C. Carter-Su, Recent advances in growth hormone signaling. Rev. Endocr. Metab. Disord. 7, 225–235 (2006)

    PubMed  CAS  Google Scholar 

  45. L.S. Argetsinger, G.S. Campbell, X. Yang, B.A. Witthuhn, O. Silvennoinen, J.N. Ihle, C. Carter-Su, Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74, 237–244 (1993)

    PubMed  CAS  Google Scholar 

  46. L.H. Hansen, X. Wang, J.J. Kopchick, P. Bouchelouche, J.H. Nielsen, E.D. Galsgaard, N. Billestrup, Identification of tyrosine residues in the intracellular domain of the growth hormone receptor required for transcriptional signaling and Stat5 activation. J. Biol. Chem. 271, 12669–12673 (1996)

    PubMed  CAS  Google Scholar 

  47. N. Carpino, R. Kobayashi, H. Zang, Y. Takahashi, S.T. Jou, J. Feng, H. Nakajima, J.N. Ihle, Identification, cDNA cloning, and targeted deletion of p70, a novel, ubiquitously expressed SH3 domaincontaining protein. Mol. Cell. Biol. 22, 7491–7500 (2002)

    PubMed  CAS  Google Scholar 

  48. T. Zhu, L. Ling, P.E. Lobie, Identification of a JAK2-independent pathway regulating growth hormone (GH)-stimulated p44/42 mitogen activated protein kinase activity. GH activation of Ral and phospholipase D is Src-dependent. J. Biol. Chem. 277, 45592–45603 (2002)

    PubMed  CAS  Google Scholar 

  49. N. Asada, Y. Takahashi, M. Wada, N. Naito, H. Uchida, M. Ikeda, M. Honjo, GH induced lipolysis stimulation in 3T3-L1 adipocytes stably expressing hGHR: analysis on signaling pathway and activity of 20 K hGH. Mol. Cell. Endocrinol. 162, 121–129 (2000)

    PubMed  CAS  Google Scholar 

  50. J.N. Fain, J.H. Ihle, S.W. Bahouth, Stimulation of lipolysis but not of leptin release by growth hormone is abolished in adipose tissue from Stat5a and b knockout mice. Biochem. Biophys. Res. Commun. 263, 201–205 (1999)

    PubMed  CAS  Google Scholar 

  51. J.O.L. Jorgensen, N. Jessen, S.B. Pedersen, E. Vestergaard, L. Gormsen, S.A. Lund, N. Billestrup, Growth hormone receptor signaling in skeletal muscle and adipose tissue in human subjects following exposure to an intravenous GH bolus. Am. J. Physiol. Endocrinol. Metab. 291, E899–E905 (2006)

    PubMed  Google Scholar 

  52. L. Moller, L. Dalman, H. Norrelund, N. Billestrup, J. Frystyk, N. Moller, J.O.L. Jorgensen, Impact of fasting on growth hormone signaling and action in muscle and fat. J. Clin. Endocrinol. Metab. 94, 965–972 (2009)

    PubMed  CAS  Google Scholar 

  53. A.C.P. Thirone, C.R.O. Carvalho, M.J.A. Saad, Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of insulin receptor substrates and Shc in rat tissues. Endocrinology 140, 55–62 (1999)

    PubMed  CAS  Google Scholar 

  54. N. Yang, Y. Huang, J. Jiang, S.J. Frank, Caveolar and lipid raft localization of the growth hormone receptor and its signaling elements: impact on growth hormone signaling. J. Biol. Chem. 279, 20898–20905 (2004)

    PubMed  CAS  Google Scholar 

  55. C.M. Szego, A. White, The influence of purified growth hormone on fasting metabolism. J. Clin. Endocrinol. Metab. 8, 594 (1948)

    PubMed  CAS  Google Scholar 

  56. K. Chihara, K. Fujieda, A. Shimatsu, T. Miki, K. Tachibana, Dose-dependent changes in body composition during growth hormone (GH) treatment in Japanese patients with adult GH deficiency: a randomized, placebo-controlled trial. Growth Horm. IGF Res. 20, 205–211 (2010)

    PubMed  CAS  Google Scholar 

  57. P.V. Carroll, W.M. Drake, K.T. Maher, K. Metcalfe, N.J. Shaw, D.B. Dunger, T.D. Cheetham, C. Camacho-Hubner, M.O. Savage, J.P. Monson, Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth. J. Clin. Endocrinol. Metab. 89, 3890–3895 (2004)

    PubMed  CAS  Google Scholar 

  58. P.J. Collipp, J. Thomas, V. Curti, R.K. Sharma, V.T. Maddaiah, S.E. Cohn, Body composition changes in children receiving human growth hormone. Metabolism. 22, 589–595 (1973)

    PubMed  CAS  Google Scholar 

  59. D.E. Berryman, E.O. List, D.T. Kohn, K.T. Coschigano, R.J. Seeley, J.J. Kopchick, Effect of growth hormone on susceptibility to diet-induced obesity. Endocrinology 147, 2801–2808 (2006)

    PubMed  CAS  Google Scholar 

  60. A. Vijayakumar, R. Novosyadlyy, Y. Wu, S. Yakar, D. LeRoith, Biological effects of growth hormone on carbohydrate and lipid metabolism. Growth Horm. IGF Res. 20, 1–7 (2010)

    PubMed  CAS  Google Scholar 

  61. J.T. Zhao, M.J. Cowley, P. Lee, V. Birzniece, W. Kaplan, K.K.Y. Ho, Identification of novel GH-regulated pathway of lipid metabolism in adipose tissue: a gene expression study in hypopituitary men. J. Clin. Endocrinol. Metab. 96, 1–9 (2011)

    Google Scholar 

  62. S. Yang, H. Mulder, C. Holm, S. Eden, Effects of growth hormone on the function of beta-adrenoceptor subtypes in rat adipocytes. Obes. Res. 12, 330–339 (2004)

    PubMed  CAS  Google Scholar 

  63. R. Doris, R.G. Vernon, M.D. Houslay, E. Kilgour, Growth hormone decreases the response to anti-lipolytic agonists and decreases the levels of Gi2 in rat adipocytes. Biochem. J. 297, 41–45 (1994)

    PubMed  CAS  Google Scholar 

  64. R.A. Doris, E. Kilgour, M.D. Houslay, R.G. Vernon, Regulation of the GTP-binding protein-based antilipolytic system of sheep adipocytes by growth hormone. J. Endocrinol. 158, 295–303 (1998)

    PubMed  CAS  Google Scholar 

  65. V.E. Chaves, D. Frasson, N.H. Kawashita, Several agents and pathways regulate lipolysis in adipocytes. Biochimie 93, 1631–1640 (2011)

    PubMed  CAS  Google Scholar 

  66. V.E. Chaves, D. Frasson, M.E. Martins-Santos, R.P. Boschini, M.A. Garófalo, W.T. Festuccia, I.C. Kettelhut, R.H. Migliorini, Glyceroneogenesis is reduced and glucose uptake is increased in adipose tissue from cafeteria diet-fed rats independently of tissue sympathetic innervation. J. Nutr. 136, 2475–2480 (2006)

    PubMed  CAS  Google Scholar 

  67. K.A. Magri, M. Adamo, D. LeRoith, T.D. Etherton, The inhibition of insulin action and glucose metabolism by porcine growth hormone in porcine adipocytes is not the result of any decrease in insulin binding or insulin receptor kinase activity. Biochem. J. 266, 107–113 (1990)

    PubMed  CAS  Google Scholar 

  68. E. Kilgour, S.A. Baldwin, D.J. Flint, Divergent regulation of rat adipocyte GLUT1 and GLUT4 glucose transporters by GH. J. Endocrinol. 145, 27–33 (1995)

    PubMed  CAS  Google Scholar 

  69. C.Y. Liu, A.L. Grant, K.H. Kim, S.E. Mills, Porcine somatotropin decreases acetyl-coA carboxylase gene expression in porcine adipose tissue. Domest. Anim. Endocrinol. 11, 125–132 (1994)

    PubMed  CAS  Google Scholar 

  70. I. Louveau, F. Gondret, GH and insulin affect fatty acid synthase activity in isolated porcine adipocytes in culture without any modifications of sterol regulatory element binding protein-1 expression. J. Endocrinol. 181, 271–280 (2004)

    PubMed  CAS  Google Scholar 

  71. S.S. Donkin, P.Y. Chiu, D. Yin, I. Louveau, B. Swencki, J. Vockroth, C.M. Evock-Clover, J.L. Peters, T.D. Etherton, Porcine somatotropin differentially down-regulates expression of the GLUT4 and fatty acid synthase genes in pig adipose tissue. J. Nutr. 126, 2568–2577 (1996)

    PubMed  CAS  Google Scholar 

  72. A.M. Mildner, S.D. Clarke, Porcine fatty acid synthase: cloning of a complementary DNA, tissue distribution of its mRNA and suppression of expression by somatotropin and dietary protein. J. Nutr. 121, 900–907 (1991)

    PubMed  CAS  Google Scholar 

  73. C.F. Semenkovich, Regulation of fatty acid synthase. Prog. Lipid Res. 36, 43–53 (1997)

    PubMed  CAS  Google Scholar 

  74. D. Yin, S.D. Clarke, J.L. Peters, T.D. Etherton, Somatotropin-dependent decrease in fatty acid synthase mRNA abundance in 3T3-F442A adipocytes is the result of a decrease in both gene transcription and mRNA stability. Biochem. J. 331, 815–820 (1998)

    PubMed  CAS  Google Scholar 

  75. R.M. Catalioto, G. Ailhaud, R. Negrel, Diacylglycerol production induced by growth hormone in Ob1771 preadipocytes arises from phosphatidylcholine breakdown. Biochem. Biophys. Res. Commun. 173, 840–848 (1990)

    PubMed  CAS  Google Scholar 

  76. T. Johansen, B. Richelsen, H.S. Hansen, N. Din, K. Malmlof, Growth hormone mediated breakdown of body fat: effects of GH on lipases in adipose tissue and skeletal muscle of old rats fed different diets. Horm. Metab. Res. 35, 243–250 (2003)

    PubMed  CAS  Google Scholar 

  77. Y. Khalfallah, G. Sassolas, F. Borson-Chazot, N. Vega, H. Vidal, Expression of insulin target genes in skeletal muscle and adipose tissue in adult patients with growth hormone deficiency: effect of one year recombinant human growth hormone therapy. J. Endocrinol. 171, 285–292 (2001)

    PubMed  CAS  Google Scholar 

  78. B. Richelsen, S.B. Pedersen, K. Kristensen, J.D. Borglum, H. Norrelund, J.S. Christiansen, J.O.L. Jorgensen, Regulation of lipoprotein lipase and hormone-sensitive lipase activity and gene expression in adipose and muscle tissue by growth hormone treatment during weight loss in obese patients. Metabolism. 49, 906–911 (2000)

    PubMed  CAS  Google Scholar 

  79. J. Oscarsson, M. Ottosson, S. Eden, Effects of growth hormone on lipoprotein lipase and hepatic lipase. J. Endocrinol. Invest. 22, 2–9 (1999)

    PubMed  CAS  Google Scholar 

  80. T. Nixon, H. Green, Contribution of growth hormone to the adipogenic activity of serum. Endocrinology 114, 527–532 (1984)

    PubMed  CAS  Google Scholar 

  81. M. Kawai, N. Namba, S. Mushiake, Y. Etani, R. Nishimura, M. Makishima, K. Ozono, Growth hormone stimulates adipogenesis of 3T3-L1 cells through activation of the STAT5a/5b-PPARgamma pathway. J. Mol. Endocrinol. 38, 19–34 (2007)

    PubMed  CAS  Google Scholar 

  82. C. Lu, P.A. Kumar, Y. Fan, M.A. Sperling, R.K. Menon, A novel effect of growth hormone on macrophage modulates macrophage-dependent adipocyte differentiation. Endocrinology 151, 2189–2199 (2010)

    PubMed  CAS  Google Scholar 

  83. W.P. Arend, S. D’Angelo, F.G. Joslin, Regulation of interleukin 1 production in human monocytes. I. Effects of gamma-interferon and cycloheximide. Clin. Exp. Immunol. 74, 377–381 (1988)

    PubMed  CAS  Google Scholar 

  84. M. Pardo, A. Roca-Rivada, L.M. Seoane, F.F. Casanueva, Obesidomics: contribution of adipose tissue secretome analysis to obesity research. Endocrine 41, 374–383 (2012)

    PubMed  CAS  Google Scholar 

  85. S. Gesta, Y.H. Tseng, C.R. Kahn, Developmental origin of fat: tracking obesity to its source. Cell 131, 242–256 (2007)

    PubMed  CAS  Google Scholar 

  86. M.C. Arkan, A.L. Hevener, F.R. Greten, S. Maeda, Z.W. Li, J.M. Long, A. Wynshaw-Boris, G. Poli, J. Olefsky, M. Karin, IKK-beta links inflammation to obesity-induced insulin resistance. Nat. Med. 11, 191–198 (2005)

    PubMed  CAS  Google Scholar 

  87. K.M. Rexrode, V.J. Carey, C.H. Hennekens, E.E. Walters, G.A. Colditz, M.J. Stampfer, W.C. Willett, J.E. Manson, Abdominal adiposity and coronary heart disease in women. JAMA 280, 1843–1848 (1998)

    PubMed  CAS  Google Scholar 

  88. J. Nedergaard, B. Cannon, The changed metabolic world with human brown adipose tissue: therapeutic visions. Cell Metab. 11, 268–272 (2010)

    PubMed  CAS  Google Scholar 

  89. D.W. Haslam, W.P. James, Obesity. Lancet. 366, 1197–1209 (2006)

    Google Scholar 

  90. E. Ferrannini, S.M. Haffner, B.D. Mitchell, M.P. Stern, Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 3, 416–422 (1991)

    Google Scholar 

  91. K.K. Miller, B.M.K. Biller, J.G. Lipman, G. Bradwin, N. Rifai, A. Klibanski, Truncal adiposity, relative growth hormone deficiency, and cardiovascular risk. J. Clin. Endocrinol. Metab. 90, 768–774 (2005)

    PubMed  CAS  Google Scholar 

  92. J. Argente, N. Caballo, V. Barrios, J. Pozo, M.T. Muñiz, J.A. Chowen, M. Hernández, Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in prepubertal children with exogenous obesity: effect of short- and long-term weight reduction. J. Clin. Endocrinol. Metab. 82, 2076–2083 (1997)

    PubMed  CAS  Google Scholar 

  93. R.M. Luque, R.D. Kineman, Impact of obesity on the growth hormone axis: evidence for a direct inhibitory effect of hyperinsulinemia on pituitary function. Endocrinology 147, 2754–2763 (2006)

    PubMed  CAS  Google Scholar 

  94. H. Vakili, Y. Jin, P.A. Cattini, Negative regulation of human growth hormone gene expression by insulin is dependent on hypoxia-inducible factor binding in primary non-tumor pituitary cells. J. Biol. Chem. 287, 33282–33292 (2012)

    PubMed  CAS  Google Scholar 

  95. N. Attia, W.V. Tamborlane, R. Heptulla, D. Maggs, A. Grozman, R.S. Sherwin, S. Caprio, The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity. J. Clin. Endocrinol. Metab. 83, 1467–1471 (1998)

    PubMed  CAS  Google Scholar 

  96. E. Ghigo, G. Aimaretti, L. Gianotti, J. Bellone, E. Arvat, F. Camanni, New approach to the diagnosis of growth hormone deficiency in adults. Eur. J. Endocrinol. 134, 352–356 (1996)

    PubMed  CAS  Google Scholar 

  97. L.B. Tankó, J.M. Bruun, P. Alexandersen, Y.Z. Bagger, B. Richelsen, C. Christiansen, P.J. Larsen, Novel associations between bioavailable estradiol and adipokines in elderly women with different phenotypes of obesity: implications for atherogenesis. Circulation 110, 2246–2252 (2004)

    PubMed  Google Scholar 

  98. D. Styne, Growth, in Greenspan’s Basic & Clinical Endocrinology, ed. by D.G. Gardner, D. Shoback (McGraw-Hill Medical, New York, 2007), pp. 171–206

    Google Scholar 

  99. A.S. Bates, W. Van’t Hoff, P.J. Jones, R.N. Clayton, The effect of hypopituitarism on life expectancy. J. Clin. Endocrinol. Metab. 81, 1169–1172 (1996)

    PubMed  CAS  Google Scholar 

  100. J.D.J. Thomas, J.P. Monson, Adult GH deficiency throughout lifetime. Eur. J. Endocrinol. 161, S97–S106 (2009)

    PubMed  CAS  Google Scholar 

  101. D.E. Cummings, G.R. Merriam, Growth hormone therapy in adults. Annu. Rev. Med. 54, 513–533 (2003)

    PubMed  CAS  Google Scholar 

  102. F. Salomon, R. Cuneo, R. Hesp, P. Sönksen, The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N. Engl. J. Med. 321, 1221–1225 (1989)

    Google Scholar 

  103. A. Binnerts, G.R. Swart, J.H.P. Wilson, N. Hoogerbrugge, H.A. Pols, J.C. Birkenhager, S.W. Lamberts, The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as body composition. Clin. Endocrinol. 37, 79–87 (1992)

    CAS  Google Scholar 

  104. J.U. Weaver, J.P. Monson, K. Noonan, W.G. John, A. Edwards, K.A. Evans, J. Cunningham, The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity and cardiovascular risk factors in hypopituitary adults. J. Clin. Endocrinol. Metab. 80, 153–159 (1995)

    PubMed  CAS  Google Scholar 

  105. A. Chrisolidou, S. Beshyah, O. Rutherford, T.J. Spinks, J. Mayet, P. Kyd, V. Anyaoku, A. Haida, B. Ariff, M. Murphy, E. Thomas, S. Robinson, R. Foale, D.G. Johnston, Effects of seven years of growth hormone replacement therapy in hypopituitary adults. J. Clin. Endocrinol. Metab. 85, 3762–3769 (2000)

    Google Scholar 

  106. M.H. Rasmussen, A. Hvidberg, A. Juul, K.M. Main, A. Gotfredsen, N.E. Skakkebaek, J. Hilsted, N.E. Skakkebae, Massive Weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects. J. Clin. Endocrinol. Metab. 80, 1407–1415 (1995)

    PubMed  CAS  Google Scholar 

  107. S. Shadid, M.D. Jensen, Effects of growth hormone administration in human obesity. Obes. Res. 11, 170–175 (2003)

    PubMed  CAS  Google Scholar 

  108. S.G. Albert, A.D. Mooradian, Low-dose recombinant human growth hormone as adjuvant therapy to lifestyle modifications in the management of obesity. J. Clin. Endocrinol. Metab. 89, 695–701 (2004)

    PubMed  CAS  Google Scholar 

  109. C.W. Ahn, C.S. Kim, J.H. Nam, H.J. Kim, J.S. Nam, J.S. Park, E.S. Kang, B.S. Cha, S.K. Lim, K.R. Kim, H.C. Lee, K.B. Hub, Effects of growth hormone on insulin resistance and atherosclerotic risk factors in obese type 2 diabetic patients with poor glycaemic control. Clin. Endocrinol. 64, 444–449 (2006)

    CAS  Google Scholar 

  110. C. Franco, J. Brandberg, L. Lönn, B. Andersson, B.A. Bengtsson, G. Johannsson, Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial. J. Clin. Endocrinol. Metab. 90, 1466–1474 (2005)

    PubMed  CAS  Google Scholar 

  111. M. Pasarica, J.J. Zachwieja, L. Dejonge, S. Redman, S.R. Smith, Effect of growth hormone on body composition and visceral adiposity in middle-aged men with visceral obesity. J. Clin. Endocrinol. Metab. 92, 4265–4270 (2007)

    PubMed  CAS  Google Scholar 

  112. T. Rosen, B.A. Bengtsson, Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336, 285–288 (1990)

    PubMed  CAS  Google Scholar 

  113. T.A. Abdu, R. Neary, T.A. Elhadd, M. Akber, R.N. Clayton, Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities. Clin. Endocrinol. 55, 209–216 (2001)

    CAS  Google Scholar 

  114. A. Besson, S. Salemi, S. Gallati, A. Jenal, R. Horn, P.S. Mullis, P.E. Mullis, Reduced longevity in untreated patients with isolated growth hormone deficiency. J. Clin. Endocrinol. Metab. 88, 3664–3667 (2003)

    PubMed  CAS  Google Scholar 

  115. E.M. Erfurth, B. Bulow, J. Eskilsson, L. Hagmar, High incidence of cardiovascular disease and increased prevalence of cardiovascular risk factors in women with hypopituitarism not receiving growth hormone treatment: preliminary results. Growth Horm. IGF Res. 9, A21–A24 (1999)

    Google Scholar 

  116. J.U. Weaver, J.P. Monson, K. Noonan, W.G. John, A. Edwards, K.A. Evans, J. Cunningham, The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults. J. Clin. Endocrinol. Metab. 80, 153–159 (1995)

    PubMed  CAS  Google Scholar 

  117. J.O. Jorgensen, N. Vahl, T.B. Hansen, L. Thuesen, C. Hagen, J.S. Christiansen, Growth hormone versus placebo treatment for one year in growth hormone deficient adults: increase in exercise capacity and normalization of body composition. Clin. Endocrinol. 45, 681–688 (1996)

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Physiology and Pharmacology, Federal University of São João del-Rei, Divinópolis, Minas Gerais, Brazil

    Valéria Ernestânia Chaves

  2. Department of Basic Sciences in Health, Federal University of Mato Grosso, Av. Fernando Corrêa da Costa, 2367-Bairro: Boa Esperança, Cuiabá, Mato Grosso, 78060-900, Brazil

    Fernando Mesquita Júnior & Gisele Lopes Bertolini

Authors
  1. Valéria Ernestânia Chaves
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fernando Mesquita Júnior
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gisele Lopes Bertolini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gisele Lopes Bertolini.

Additional information

Valéria Ernestânia Chaves and Fernando Mesquita Júnior contributed equally to this manuscript.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chaves, V.E., Júnior, F.M. & Bertolini, G.L. The metabolic effects of growth hormone in adipose tissue. Endocrine 44, 293–302 (2013). https://doi.org/10.1007/s12020-013-9904-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-013-9904-3

Keywords

Search

Navigation